The presence of collagen fragments, α1-microglobulin, β2MG, A1AT, and uromodulin appear to be promising biomarkers for detecting patients with DM2 at high risk of developing chronic kidney disease. This evidence concerns the gene SERPINA1 and chronic kidney disease.